E-LIB Suche - Ergebnisse für: Hamilton, Erika

1

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:

Bardia, Aditya ; Jhaveri, Komal ; Kalinsky, Kevin...
Future Oncology. 20 (2024) 8 - p. 423-436 , 2024

Link: https://doi.org/10.2217/..

2

The HER2-directed antibody-drug conjugate DHES0815A in adva..:

Lewis, Gail D. ; Li, Guangmin ; Guo, Jun...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Cortés, Javier ; Hurvitz, Sara A. ; Im, Seock-Ah...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

4

Author Correction: Inhibition of lysine acetyltransferase K..:

Mukohara, Toru ; Park, Yeon Hee ; Sommerhalder, David...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

5

A Relative Bioavailability, Bioequivalence, and Food Effect..:

Falchook, Gerald ; Patnaik, Amita ; Richardson, Debra L....
Clinical Therapeutics. 46 (2024) 3 - p. 228-238 , 2024

Link: https://doi.org/10.1016/..

6

Inhibition of lysine acetyltransferase KAT6 in ER+HER2− met..:

Mukohara, Toru ; Park, Yeon Hee ; Sommerhalder, David...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

7

Long-term follow-up of efficacy and safety of selinexor mai..:

Makker, Vicky ; Perez-Fidalgo, Jose Alejandro ; Valabrega, Giorgio...
Gynecologic Oncology. 185 (2024) - p. 202-211 , 2024

Link: https://doi.org/10.1016/..

8

Trastuzumab deruxtecan versus trastuzumab emtansine in pati..:

Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang...
The Lancet. 401 (2023) 10371 - p. 105-117 , 2023

Link: https://doi.org/10.1016/..

9

XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody dr..:

Hamilton, Erika ; Spira, Alexander ; Adams, Sylvia...
Gynecologic Oncology. 176 (2023) - p. S158 , 2023

Link: https://doi.org/10.1016/..

10

Phase 1b study of pan‐AKT inhibitor vevorisertib alone or w..:

Pant, Shubham ; Hamilton, Erika ; Ulahannan, Susanna V....
Cancer. 129 (2023) 12 - p. 1919-1929 , 2023

Link: https://doi.org/10.1002/..

11

The evolving landscape of antibody-drug conjugates in gynec..:

Tolcher, Anthony ; Hamilton, Erika ; Coleman, Robert L.
Cancer Treatment Reviews. 116 (2023) - p. 102546 , 2023

Link: https://doi.org/10.1016/..

12

Novel endocrine therapies: What is next in estrogen recepto..:

Corti, Chiara ; De Angelis, Carmine ; Bianchini, Giampaolo...
Cancer Treatment Reviews. 117 (2023) - p. 102569 , 2023

Link: https://doi.org/10.1016/..

13

DKK1 is a predictive biomarker for response to DKN-01: Resu..:

Arend, Rebecca ; Dholakia, Jhalak ; Castro, Cesar...
Gynecologic Oncology. 172 (2023) - p. 82-91 , 2023

Link: https://doi.org/10.1016/..

14

The PD-1- and LAG-3-targeting bispecific molecule tebotelim..:

Luke, Jason J. ; Patel, Manish R. ; Blumenschein, George R....
Nature Medicine. 29 (2023) 11 - p. 2814-2824 , 2023

Link: https://doi.org/10.1038/..

15

Evolving perspectives on the treatment of HR+/HER2+ metasta..:

Pegram, Mark ; Pietras, Richard ; Dang, Chau T....
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..